Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.67 USD | +3.73% | +3.27% | -4.73% |
May. 31 | Sector Update: Health Care Stocks Higher Late Afternoon | MT |
May. 31 | Sector Update: Health Care | MT |
Business Summary
Number of employees: 118
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ed Feener
FOU | Founder | 64 | 04-03-25 |
Ben Palleiko
CEO | Chief Executive Officer | 58 | 16-07-31 |
Paul Audhya
CTO | Chief Tech/Sci/R&D Officer | 51 | 21-05-02 |
Ryan Baker
IRC | Investor Relations Contact | - | 23-04-30 |
Nicole Sweeny
PRN | Corporate Officer/Principal | 49 | 23-07-24 |
Christopher Yea
PRN | Corporate Officer/Principal | 61 | 16-10-31 |
Mike Smith
PRN | Corporate Officer/Principal | - | 16-01-31 |
Rachel Morten
LAW | General Counsel | - | 15-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Brian Pereira
CHM | Chairman | 65 | 19-01-31 |
Ben Palleiko
CEO | Chief Executive Officer | 58 | 16-07-31 |
Albert Cha
BRD | Director/Board Member | 51 | 15-12-31 |
Edward Unkart
BRD | Director/Board Member | 74 | 14-11-30 |
Nancy Stuart
BRD | Director/Board Member | 65 | 21-03-17 |
Patrick Treanor
BRD | Director/Board Member | - | 22-05-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 42,188,296 | 41,670,541 ( 98.77 %) | 0 | 98.77 % |
Company contact information
KalVista Pharmaceuticals, Inc.
55 Cambridge Parkway Suite 901 East
02142, Cambridge
+857 999 0075
http://www.kalvista.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.73% | 492M | |
-2.29% | 89.87B | |
-3.95% | 37.57B | |
-13.07% | 32.75B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B |
- Stock Market
- Equities
- KALV Stock
- Company KalVista Pharmaceuticals, Inc.